The Middle East & Africa skin cancer diagnostics market is expected to reach US$ 214.3 million by 2028 from US$ 160.5 million in 2021; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028.
Technologically advanced dermatoscopes aid in better visualizing skin cancers and has improved diagnostics sensitivity by 10–30%. Similarly, developments in AI technology enabled its application in the early detection of skin cancer. In February 2022, researchers at Fraunhofer Center for Assistive Information and Communication Solutions (AICOS) in Porto and Lisbon announced their Derm.AI software that offers a smooth primary assessment of skin lesions on the skin surface that look potentially dangerous. It combines the photos of skin lesions taken from smartphones with image analysis software and AI. The software is likely to help dermatologists to access and analyze cases and risks of skin cancer. At present, the researchers of the Derm.AI solution aim to improve the existing teledermatology processes in the Portuguese National Health System. They are also working on developing solutions for analyzing the results from mobile apps, further enhancing the deep-learning model of Derm.AI. The software was developed in partnership with shared services of the Ministry of Health and clinical partners, namely IPO Coimbra, CHUP, and ULS Guarda.
With the new features and technologies, vendors attract new customers and expand their footprints in emerging markets. This factor is driving the growth of the Middle East & Africa skin cancer diagnostics market at a promising CAGR.
Middle East & Africa Skin Cancer Diagnostics Market Revenue And Forecast To 2028 (US$ Million)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
The skin cancer diagnostics market is segmented into type and screening type. Based on type, the market is segmented into melanoma and non-melanoma. Based on screening type, the market is segmented into skin biopsy, dermatoscopy, lymph node biopsy, imaging tests, and blood tests. Based on country, the market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa.
AMLo Biosciences Limited; DermLite LLC; bioMerieux SA; Hoffmann-La Roche Ltd.; and Michelson Diagnostics Ltd. are among the leading companies in the Middle East & Africa skin cancer diagnostics market.
Middle East and Africa Skin Cancer Diagnostics Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 160.5 Million |
Market Size by 2028 | US$ 214.3 Million |
Global CAGR (2021 - 2028) | 4.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- AMLo Biosciences Limited
- DermLite LLC
- F. HOFFMANN-LA ROCHE LTD
- bioMerieux SA
- Michelson Diagnostics Ltd.